5 GLP-1 trends to expect in 2026: Expanded uses, oral options, and more Originally developed for Type 2 diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the weight-loss medication market
At Vive Ageless Weight Loss Center, we strive to provide innovative, scientifically supported solutions to help you achieve your weight loss and wellness goals
For patients using GLP-1 medications or considering future therapies like retatrutide, the goal should be fat loss with lean-mass protection
Back McLean, BA, Wong, CK, Campbell, JE, et al (2021) 'Revisiting the complexity of GLP-1 action from sites of synthesis to receptor activation', Endocrine Reviews , 42/2, 101-32
Combat GLP 1 Skin Laxity With Sofwave The wellness world has been buzzing with conversations around GLP-1 medications like Ozempic and Wegovy